Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin versus crystalloid resuscitation in severe sepsis shock
IRCT2016040316473N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of albumin (human) in septic shock and sepsis (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Survival. Started Jun 2016; status: completed.
02
Drugs
albumin (human)
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on IRCT2016040316473N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016040316473N5.